Fleury Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Fleury is de winst gegroeid met een gemiddeld jaarlijks percentage van 14.7%, terwijl de Healthcare industrie de winst jaarlijks groeide met 18.2%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 22.1% per jaar. Het rendement op eigen vermogen van Fleury is 11.2%, en het heeft een nettomarge van 8.1%.

Belangrijke informatie

14.7%

Groei van de winst

4.0%

Groei van de winst per aandeel

Healthcare Groei van de industrie11.6%
Inkomstengroei22.1%
Rendement op eigen vermogen11.2%
Nettomarge8.1%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Mar 14
Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Recent updates

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Jun 18
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Apr 16
The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Mar 14
Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Jan 05
Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Oct 05
Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Jun 27
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Feb 25
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Sep 26
At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Sep 08
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

Jul 01
Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Jun 10
When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Apr 10
Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

Mar 24
Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Feb 08
At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Dec 08
Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 05
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Oct 21
Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Aug 24
Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Jul 31
Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Jul 07
Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Apr 30
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

Apr 12
Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Mar 29
At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Mar 16
Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Mar 01
Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 28
Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Feb 15
What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Feb 02
Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Jan 03
Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Dec 28
Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Dec 12
Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Nov 29
Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Aug 30
Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Aug 18
Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Aug 03
Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Opbrengsten en kosten

Hoe Fleury geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

BOVESPA:FLRY3 Opbrengsten, kosten en inkomsten (BRL Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 247,5506148950
30 Jun 247,4575978860
31 Mar 247,1384988880
31 Dec 236,4714248270
30 Sep 235,8813737510
30 Jun 235,1582956610
31 Mar 234,6102915300
31 Dec 224,4633084980
30 Sep 224,3663485340
30 Jun 224,2483475510
31 Mar 224,0693425140
31 Dec 213,8733504810
30 Sep 213,7834193990
30 Jun 213,6294563350
31 Mar 213,1513173160
31 Dec 202,9722573210
30 Sep 202,7641743090
30 Jun 202,6451333250
31 Mar 202,9182783300
31 Dec 192,9053123200
30 Sep 192,8403143140
30 Jun 192,7673142960
31 Mar 192,7123282970
31 Dec 182,6643322960
30 Sep 182,5923382810
30 Jun 182,5243342750
31 Mar 182,4493352670
31 Dec 172,3833212570
30 Sep 172,3243312600
30 Jun 172,2483072570
31 Mar 172,1762662490
31 Dec 162,0962292430
30 Sep 162,0461802330
30 Jun 162,0021522290
31 Mar 161,9561392240
31 Dec 151,8951072220
30 Sep 151,845942240
30 Jun 151,801902160
31 Mar 151,730732090
31 Dec 141,679862090
30 Sep 141,646732060
30 Jun 141,634602150
31 Mar 141,659662230
31 Dec 131,657612160

Kwaliteitswinsten: FLRY3 heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (8.1%) FLRY3 } zijn hoger dan vorig jaar (6.3%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van FLRY3 is de afgelopen 5 jaar met 14.7% per jaar gegroeid.

Versnelling van de groei: De winstgroei van FLRY3 over het afgelopen jaar ( 64.3% ) overtreft het 5-jarig gemiddelde ( 14.7% per jaar).

Winst versus industrie: De winstgroei FLRY3 over het afgelopen jaar ( 64.3% ) overtrof de Healthcare -sector 64.3%.


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 11.2% ) van FLRY3 wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden